1. Home
  2. NVCR vs LION Comparison

NVCR vs LION Comparison

Compare NVCR & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • LION
  • Stock Information
  • Founded
  • NVCR 2000
  • LION 1997
  • Country
  • NVCR Switzerland
  • LION United States
  • Employees
  • NVCR N/A
  • LION N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • LION Movies/Entertainment
  • Sector
  • NVCR Health Care
  • LION Consumer Discretionary
  • Exchange
  • NVCR Nasdaq
  • LION Nasdaq
  • Market Cap
  • NVCR 1.9B
  • LION 1.9B
  • IPO Year
  • NVCR 2015
  • LION N/A
  • Fundamental
  • Price
  • NVCR $19.11
  • LION $7.24
  • Analyst Decision
  • NVCR Buy
  • LION Strong Buy
  • Analyst Count
  • NVCR 6
  • LION 3
  • Target Price
  • NVCR $32.83
  • LION $11.50
  • AVG Volume (30 Days)
  • NVCR 941.3K
  • LION 457.0K
  • Earning Date
  • NVCR 07-24-2025
  • LION 05-22-2025
  • Dividend Yield
  • NVCR N/A
  • LION N/A
  • EPS Growth
  • NVCR N/A
  • LION N/A
  • EPS
  • NVCR N/A
  • LION N/A
  • Revenue
  • NVCR $621,711,000.00
  • LION $3,005,900,000.00
  • Revenue This Year
  • NVCR $5.56
  • LION $6.05
  • Revenue Next Year
  • NVCR $9.15
  • LION $6.28
  • P/E Ratio
  • NVCR N/A
  • LION N/A
  • Revenue Growth
  • NVCR 18.27
  • LION 2.59
  • 52 Week Low
  • NVCR $14.17
  • LION $5.98
  • 52 Week High
  • NVCR $34.13
  • LION $12.84
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 58.46
  • LION 55.99
  • Support Level
  • NVCR $18.66
  • LION $6.45
  • Resistance Level
  • NVCR $20.06
  • LION $6.81
  • Average True Range (ATR)
  • NVCR 0.86
  • LION 0.35
  • MACD
  • NVCR 0.19
  • LION 0.01
  • Stochastic Oscillator
  • NVCR 71.98
  • LION 78.06

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About LION Lionsgate Studios Corp. Common Shares

Lionsgate Studios Corp is a company encompasses world-class motion picture and television studio operations and the STARZ-branded premium global subscription platforms to bring a unique and varied portfolio of entertainment to consumers around the world. The Studio Business consists of the Motion Picture and Television Production reportable segments, together with substantially all of Lionsgate's corporate general and administrative costs. Motion Picture consists of the development and production of feature films, acquisition of North American and worldwide distribution rights. Television Production consists of the development, production and worldwide distribution of television productions including television series, television movies and mini-series, and non-fiction programming.

Share on Social Networks: